CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 11,213 shares at an average $3.89 ($43,603)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 500 shares at $3.71 ($1,855)
- 4 Open-market buy Director bought 4,187 shares at an average $3.65 ($15,300)
- 4 Open-market buy Director bought 3,000 shares at $3.69 ($11,070)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 200,000 shares
- 4 Open-market sale Director sold 320,000 shares
- 4 Open-market buy Director bought 120,000 shares
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 200,000 shares at $3.81 ($762,000)
Page 17 of 37 · 722 filings